序号 |
标题 |
次数 |
作者 |
发布时间 |
81901 |
DOTA-VEGFDEE ,DOTA偶联突变体VEGFDEE |
87 |
wyh |
2024-12-03 |
81902 |
3,6-双(3,5-二甲基-吡唑-1-酰基)-1,2,4-四嗪(BT) |
99 |
WYQ |
2024-12-03 |
81903 |
DOTA-Cy5.5-NP,聚合物修饰上双功能螯合剂DOTA和近红外染料Cy5.5 |
105 |
wyh |
2024-12-03 |
81904 |
1,2,3,4-四嗪-1,3-二氧化物;Benzo-1,2,3,4-tetrazine-1,3-dioxide |
119 |
WYQ |
2024-12-03 |
81905 |
DOTA-dPEG2-R954,DOTA偶联R954衍生物 |
102 |
wyh |
2024-12-03 |
81906 |
3,6二氨基-1,2,4,5-四嗪-1,4-二氧化物(DATZO2);3,6-Diamino-1,2,4,5-tetrazine-1,4-dioxide |
99 |
WYQ |
2024-12-03 |
81907 |
3,6-双(3,5-二甲基-吡唑-1-酰基)-1,2,4-四嗪(BT);3,6-bis ( 3,5-dimethyl-pyrazol-1-oyl)-1,2,4,5-tetrazine |
118 |
WYQ |
2024-12-03 |
81908 |
3,6-双胍基-1,2,4,5-四嗪(DGTZ) |
146 |
WYQ |
2024-12-03 |
81909 |
氨基酸衍生物L-4-四嗪-苯丙氨酸 |
133 |
WYQ |
2024-12-03 |
81910 |
3,6-双(1-氢-1,2,3,4-四唑-5-氨基)-1,2,4,5-四嗪(BTATz) |
106 |
WYQ |
2024-12-03 |
81911 |
3-氨基-6-(3,5-二甲基吡唑基-1-基)-1,2,4-三唑[4,3-b]-1,2,4,5-四嗪(ADTTz) |
105 |
WYQ |
2024-12-03 |
81912 |
3-[(对甲氧基苯基)亚甲基腙]-6-(3,5-二甲基吡唑)-1,2,4,5-四嗪(DPMHT) |
121 |
WYQ |
2024-12-03 |
81913 |
3-[(3-甲氧基-4-羟基苯基)亚甲基腙]-6-(3,5-二甲基吡唑)-1,2,4,5-四嗪(DMPT) |
201 |
WYQ |
2024-12-03 |
81914 |
[Tc-99m]HYNIC-PEG(11)-Tz;[Tc-99m]标记联肼尼克酰胺多肽--PEG11-四嗪 |
96 |
WYQ |
2024-12-03 |
81915 |
maleimide-PEG-NHS ,马来酰亚胺-聚乙二醇-活性酯 |
92 |
wyh |
2024-12-03 |
81916 |
氨基聚乙二醇功能化的金纳米粒,AuNP-PEG-NH |
143 |
wyh |
2024-12-03 |
81917 |
Gd-DOTA修饰星形两亲性葡聚糖胶束 |
90 |
wyh |
2024-12-03 |
81918 |
IRFE-PEG-DOTA(IPD), 近红外二区(NIR II)有机染料 |
164 |
wyh |
2024-12-03 |
81919 |
[18F]FN-PEG4-Tz-TCO-GK-PEG4-5F7 ([18F]FN-GK-5F7) |
113 |
WYQ |
2024-12-03 |
81920 |
64Cu]Cu-NOTA-PEG7-H-Tz |
129 |
WYQ |
2024-12-03 |
81921 |
DOTA-PEG-DSPE ,DOTA-聚乙二醇-磷脂 |
96 |
wyh |
2024-12-03 |
81922 |
3,6-二氨基-1,2,4,5-四嗪(DATZ) |
88 |
WYQ |
2024-12-03 |
81923 |
DOTA-PEG(4)-BBN ;DOTA-四聚乙二醇-铃蟾肽 |
87 |
wyh |
2024-12-03 |
81924 |
3,6-二氨基-1,2,4,5-四嗪-1,4-二氧化物 |
134 |
WYQ |
2024-12-03 |
81925 |
1,6-二氢-1,2,4,5-四嗪化合物(1,6-Dihydro-1,2,4,5-Tetrazines) |
184 |
WYQ |
2024-12-03 |
81926 |
TCO-CC49 ,TCO功能化CC49抗体 |
120 |
wyh |
2024-12-03 |
81927 |
[111In]In-DOTA-PEG11-BisPy-Tz |
115 |
WYQ |
2024-12-03 |
81928 |
3,6-二烷基-1,2,4,5-四嗪(或-s-四嗪);3,6-dialkyl-1,2,4,5-tetrazines (or -s-tetrazines) |
102 |
WYQ |
2024-12-03 |
81929 |
3,6-二烷基-1,2,4,5-四嗪(或-s-四嗪);3,6-dialkyl-1,2,4,5-tetrazines (or -s-tetrazines) |
98 |
WYQ |
2024-12-03 |
81930 |
3,6-双(2-吡啶基)-1,2,4,5-四嗪(bptz);3,6-bis(2-pyridyl)-1,2,4,5-tetrazine |
114 |
WYQ |
2024-12-03 |
81931 |
(DOTA)5-decalysine , (DOTA)5-十氢赖氨酸 |
85 |
wyh |
2024-12-03 |
81932 |
3,6-dihydrazino-1,2,4,5-tetrazine(DHT) |
122 |
WYQ |
2024-12-03 |
81933 |
5-TAMRA-Tz;S-四嗪近红外花菁染料;5-TAMRA-tetrazine |
130 |
WYQ |
2024-12-03 |
81934 |
[64Cu]Cu-SarAr-Tz;(64)Cu标记四嗪放射性配体 |
197 |
WYQ |
2024-12-03 |
81935 |
DOTA-monoamide,DOTA-单酰胺复合物 |
101 |
wyh |
2024-12-03 |
81936 |
DOTA-PEG-RGD, DOTA-聚乙二醇-多肽 |
155 |
wyh |
2024-12-03 |
81937 |
DOTA-PEGn-Cys-VS ,单分散PEG偶联螯合剂DO |
109 |
wyh |
2024-12-03 |
81938 |
甲氧基DOTA ,MeO-DOTA |
201 |
wyh |
2024-12-03 |
81939 |
DOTA-BASS , DOTA偶联sst拮抗剂 |
192 |
wyh |
2024-12-03 |
81940 |
DOTA-phenylalanine,DOTA-苯丙氨酸 |
114 |
wyh |
2024-12-03 |
81941 |
DOTA−Lysine−Biotin, DOTA -赖氨酸-生物素 |
108 |
wyh |
2024-12-03 |
81942 |
DOTA-GA,螯合剂DOTA肽缀合物 |
132 |
wyh |
2024-12-03 |
81943 |
DOTA共轭二膦酸盐,DOTA-HBP |
121 |
wyh |
2024-12-03 |
81944 |
DOTA-神经介素n ,DOTA-Neuromedin N |
108 |
wyh |
2024-12-03 |
81945 |
tris-烯丙基-DOTA , tris-allyl-DOTA |
89 |
wyh |
2024-12-03 |